Diagnostic Imaging Market Outlook 2021: Leading Supplier Marketing Tactics and Technological Know-How
NEW YORK, Nov. 17, 2017 /PRNewswire/ -- This new report from LeadingMarketResearch.com contains 144 pages and provides analysis of the global diagnostic imaging market and leading suppliers' marketing tactics and technological know-how. The report presents a worldwide strategic overview of the diagnostic imaging market, including:
Estimates of the market size and growth.
Sales forecasts by geographic region and modality.
Review of the U.S. and international technological, regulatory, economic, demographic and social trends with potentially significant impact on the diagnostic imaging industry during the next five years.
Analysis of major geographic regions, including North America, Europe, Japan and Latin America.
Discussion of trends in X-ray, ultrasound, MRI, CT, nuclear medicine, PET, PACS and other technologies.
The companies analyzed in the report include Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba. The company profiles include:
The U.S. and international sales force size in major geographic regions.
Selling options, including rental plans, leasing and others.
Internally developed and acquired diagnostic imaging and related technologies, including X-ray, ultrasound, MRI, CT, nuclear medicine, PET, PACS, and others.
About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Bioforum, the Data Masters, a leading contract research organization (CRO) focused on the delivery of biometric services and solutions to the global clinical trials industry, today announced the launch of SUBMIT24 in its beta version during Q3 2024,...
Calliditas Therapeutics AB , ("Calliditas") today announced that the global open-label extension (OLE) study to the Phase 3 NefIgArd study showed a treatment response consistent with the NefIgArd study across endpoints of urine protein to creatinine...
CSL Vifor and Travere Therapeutics, Inc., today announced that the European Commission has granted conditional marketing authorization (CMA) for FILSPARI (sparsentan) for the...
Tetra Pharm Technologies and Glysious are pleased to announce a strategic collaboration aimed at developing a ground-breaking transdermal drug delivery system complementing several of Tetra Pharm Technologies' pipeline candidates. The...